诱导多能干细胞
良好制造规范
再生医学
人诱导多能干细胞
干细胞
医学
生物技术
风险分析（工程）
生物
胚胎干细胞
细胞生物学
生物化学
基因
监管事务
作者
Adeleh Taei,Fatemehsadat Sajadi,Sarvenaz Salahi,Zahra Enteshari,Nasrin Falah,Zahra Shiri,Saeed Abasalizadeh,Ensiyeh Hajizadeh‐Saffar,Seyedeh‐Nafiseh Hassani,Hossein Baharvand
标识
DOI：10.1080/14712598.2024.2443079
摘要
hPSC-based products continue to show promise for the treatment of a variety of diseases. While clinical trials support the relative safety and efficacy of hPSC-based products, further investigation is required to explore the clinical challenges and achieve exclusive regulations for hPSC-based cell therapies.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
大力的冬萱
Avalonx
cdercder
ale
weixia
科研狗
arniu2008
潇洒的惋清
Copyright
OK
sagitar
行走的荷尔蒙
热心市民小红花
科研啦
liuzhuohao
卡乐瑞咩吹可
天晴
Oracle
昏睡的蟠桃
皖公网安备34019202002308
